학술논문
Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience.
Document Type
Journal Article
Source
Subject
*INSULIN aspart
*TYPE 2 diabetes
*INSULIN
*GLYCEMIC control
*BODY mass index
*
*
*
*
Language
ISSN
1734-1922
Abstract